Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

Arvind Dasari; Axel Grothey; Scott Kopetz

doi:10.1200/JCO.2018.78.9032

Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

Arvind Dasari, Axel Grothey, Scott Kopetz

GI Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

48 Scopus citations

Original language	English (US)
Pages (from-to)	3437-3440
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	36
Issue number	35
DOIs	https://doi.org/10.1200/JCO.2018.78.9032
State	Published - Dec 10 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2018.78.9032

Cite this

@article{38ade39bba474d6d882f0d67a91ae4f5,

title = "Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies",

author = "Arvind Dasari and Axel Grothey and Scott Kopetz",

note = "Funding Information: Supported by the National Cancer Institute at the National Institutes of Health (Grants No. P30CA016672 [S.K. and A.D.] and R01CA184843 [S.K.]) and The University of Texas MD Anderson Cancer Center Moonshots Program (S.K.).",

year = "2018",

month = dec,

day = "10",

doi = "10.1200/JCO.2018.78.9032",

language = "English (US)",

volume = "36",

pages = "3437--3440",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "35",

}

TY - JOUR

T1 - Circulating tumor DNA–defined minimal residual disease in solid tumors

T2 - Opportunities to accelerate the development of adjuvant therapies

AU - Dasari, Arvind

AU - Grothey, Axel

AU - Kopetz, Scott

N1 - Funding Information: Supported by the National Cancer Institute at the National Institutes of Health (Grants No. P30CA016672 [S.K. and A.D.] and R01CA184843 [S.K.]) and The University of Texas MD Anderson Cancer Center Moonshots Program (S.K.).

PY - 2018/12/10

Y1 - 2018/12/10

UR - http://www.scopus.com/inward/record.url?scp=85058280775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058280775&partnerID=8YFLogxK

U2 - 10.1200/JCO.2018.78.9032

DO - 10.1200/JCO.2018.78.9032

M3 - Comment/debate

C2 - 30376428

AN - SCOPUS:85058280775

SN - 0732-183X

VL - 36

SP - 3437

EP - 3440

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 35

ER -

Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this